Precision Treatment Seen to Improve Response in Eligible Patients with Advanced Prostate and Other Cancers

Precision Treatment Seen to Improve Response in Eligible Patients with Advanced Prostate and Other Cancers
Patients with advanced cancers have longer responses to treatment when those treatments are tailored to the individual as opposed to receiving conventional therapies, according to the results of a clinical trial presented at the recent Molecular Analysis for Personalised Therapy (MAP) conference in London. The study enrolled patients with a number of advanced cancers, including prostate, breast, lung, head and

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *